NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 55 filers reported holding NUVALENT INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $918,987,373 | +9.0% | 19,991,024 | 0.0% | 20.25% | +12.5% |
| Q2 2023 | $843,021,482 | +61.6% | 19,991,024 | 0.0% | 18.00% | +54.8% |
| Q1 2023 | $521,565,816 | -12.4% | 19,991,024 | 0.0% | 11.63% | -5.6% |
| Q4 2022 | $595,332,695 | +58.3% | 19,991,024 | +3.4% | 12.32% | +64.7% |
| Q3 2022 | $375,990,000 | +43.4% | 19,341,024 | 0.0% | 7.48% | +38.4% |
| Q2 2022 | $262,264,000 | -2.4% | 19,341,024 | 0.0% | 5.41% | -9.9% |
| Q1 2022 | $268,647,000 | -27.0% | 19,341,024 | 0.0% | 6.01% | -22.2% |
| Q4 2021 | $368,253,000 | -15.6% | 19,341,024 | 0.0% | 7.72% | -9.3% |
| Q3 2021 | $436,140,000 | – | 19,341,024 | – | 8.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,341,024 | $368,253,000 | 7.72% |
| Fairmount Funds Management LLC | 914,614 | $17,414,000 | 5.74% |
| Bain Capital Life Sciences Investors, LLC | 3,428,014 | $65,269,000 | 5.18% |
| VR Adviser, LLC | 803,951 | $15,307,000 | 2.09% |
| Boxer Capital, LLC | 1,210,192 | $23,042,000 | 0.90% |
| Avoro Capital Advisors LLC | 1,102,671 | $18,431,000 | 0.31% |
| BVF INC/IL | 448,512 | $8,540,000 | 0.31% |
| Logos Global Management LP | 134,650 | $2,563,000 | 0.26% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,180,696 | $22,480,000 | 0.23% |
| Perceptive Advisors | 1,500,000 | $28,560,000 | 0.22% |